NDC 70069-161
Cisatracurium Besylate 2 mg per 1 mL injection
On the label: Somerset Therapeutics, LLC.
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Somerset Therapeutics, LLC names for other drugs.
Recalls
- Nov 26, 2025 · Class III · Somerset Therapeutics Llc
Subpotent product:out of specification assay results observed during long term stability testing.
Lots: Lot#: A250043, EXP Date 06/30/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cisatracurium: every company that makes it
- Form
- injection, intravenous
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA209132
- On the market since
- Aug 2, 2019
- Package NDCs
70069-161-0170069-161-10- Official label
- DailyMed (National Library of Medicine), updated Apr 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?